| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate |
2001-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2003-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100405919-B1 |
| titleOfInvention |
Pharmaceutical composition for immunological enhancement comprising N-terminal peptide of p43 as an effective component |
| abstract |
The present invention relates to a pharmaceutical composition for immuno-enhancing, and provides an immuno-enhancing pharmaceutical composition comprising a peptide having an amino acid sequence represented by SEQ ID NO: 1 to SEQ ID NO: 3 as an active ingredient. Since the N-terminal peptides of p43 according to the present invention have excellent cytokine (cytokine) activity can improve the immune response can be used as an adjuvant. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100515016-B1 |
| priorityDate |
2001-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |